MX2018010652A - Composiciones farmaceuticas. - Google Patents

Composiciones farmaceuticas.

Info

Publication number
MX2018010652A
MX2018010652A MX2018010652A MX2018010652A MX2018010652A MX 2018010652 A MX2018010652 A MX 2018010652A MX 2018010652 A MX2018010652 A MX 2018010652A MX 2018010652 A MX2018010652 A MX 2018010652A MX 2018010652 A MX2018010652 A MX 2018010652A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
stereoisomer
compound
formula
disclosed
Prior art date
Application number
MX2018010652A
Other languages
English (en)
Inventor
Mrutunjaya Sahu
Mohammad Ajmal Shareef
Ajaykumar Handa
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of MX2018010652A publication Critical patent/MX2018010652A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen composiciones farmacéuticas estables que comprenden un compuesto de Formula (I) o un estereoisómero o un derivado farmacéuticamente aceptable del mismo. (ver fórmula).
MX2018010652A 2016-01-12 2017-01-12 Composiciones farmaceuticas. MX2018010652A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201621001033 2016-01-12
PCT/IB2017/050155 WO2017122147A1 (en) 2016-01-12 2017-01-12 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX2018010652A true MX2018010652A (es) 2021-07-16

Family

ID=58448576

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018010652A MX2018010652A (es) 2016-01-12 2017-01-12 Composiciones farmaceuticas.

Country Status (10)

Country Link
US (1) US10857171B2 (es)
EP (1) EP3402467A1 (es)
KR (1) KR20180101509A (es)
CN (1) CN108778255B (es)
AU (1) AU2017206672A1 (es)
CA (1) CA3014741A1 (es)
MX (1) MX2018010652A (es)
RU (1) RU2018129198A (es)
WO (1) WO2017122147A1 (es)
ZA (1) ZA201705782B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11126550B1 (en) 2017-09-01 2021-09-21 Crossbar, Inc Integrating a resistive memory system into a multicore CPU die to achieve massive memory parallelism

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0113472A (pt) * 2000-08-22 2003-07-01 Basilea Pharmaceutica Ag Macrolìdeos com atividade antibacteriana
GB0031312D0 (en) * 2000-12-21 2001-02-07 Glaxo Group Ltd Macrolides
FR2882522B1 (fr) * 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
WO2010136971A1 (en) * 2009-05-27 2010-12-02 Wockhardt Research Centre Ketolide compounds having antimicrobial activity
DK2673285T3 (en) * 2010-12-09 2017-10-16 Wockhardt Ltd Ketolide compounds
US8993739B2 (en) * 2011-03-22 2015-03-31 Wockhardt Ltd. Process for preparation of ketolide compounds

Also Published As

Publication number Publication date
US20180028548A1 (en) 2018-02-01
CN108778255A (zh) 2018-11-09
CN108778255B (zh) 2020-11-13
EP3402467A1 (en) 2018-11-21
WO2017122147A1 (en) 2017-07-20
KR20180101509A (ko) 2018-09-12
US10857171B2 (en) 2020-12-08
RU2018129198A (ru) 2020-02-13
AU2017206672A1 (en) 2018-08-23
CA3014741A1 (en) 2017-07-20
ZA201705782B (en) 2018-12-19

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
PH12016501517B1 (en) Tetrazolone-substituted dihydropyridinone mgat2 inhibitors
MY194116A (en) Pharmaceutical compounds
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
AU2018297348A1 (en) Compositions for parenteral administration of therapeutic agents
MX2015015562A (es) Dihidropiridinona como inhibidores de monoacilglicerol aciltransferasa 2.
JOP20200030A1 (ar) مركب خماسي الحلقة
PH12017502319A1 (en) Injectable pharmaceutical formulations of lefamulin
PH12019500370A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
MA39877A (fr) Formes solides d'un composé pharmaceutiquement actif
IN2013MU03704A (es)
MX2018010652A (es) Composiciones farmaceuticas.
TR201714882A2 (tr) Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
IN2014MU00859A (es)
IN2013MU03309A (es)
IN2013MU03422A (es)
IN2013MU03308A (es)
MX2017010992A (es) Composiciones farmaceuticas estables que comprenden agente antibacteriano.
IN2013MU03421A (es)
SG11202108949PA (en) Pharmaceutical composition comprising benzimidazole derivative compound
EP3806838A4 (en) PHARMACEUTICAL COMPOSITIONS WITH POH DERIVATIVES
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2014MU01194A (es)
MX2018005376A (es) Derivados de azetidina para formacion de imágenes de tau.